After Skyrocketing Nearly 200%: Is Bloom Energy a Buy in 2026?
Bloom Energy has drawn big investor attention after a dramatic rally. This guide breaks down what the company does, w...
Volatility Vs Returns Index Funds Retirement
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articles
Is Sandisk Next Nvidia? A Fresh AI Stock Debate Ahead
As AI accelerates, investors wonder if Sandisk could become the next Nvidia. This article dives into Sandisk's AI-sto...
This Tiny Quantum Stock Could Surge 200% This Year
A small, overlooked quantum company could ride a wave of lab-to-market commercialization. This guide breaks down why ...
Strategist Unveils Formula for How Long Iran Conflict Lasts
A seasoned strategist released a clockwork model to estimate how long the Iran conflict could endure, tying escalatio...
Barclays Hikes Atlassian Price Target to $112 on ARR
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
AGNC Investment's Interest Spread Outweighs Its 14% Yield
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
SpaceX IPO Fuels $1.4 Billion Trading Frenzy on Hyperliquid
Rumors of a SpaceX public offering sparked a dramatic surge in crypto derivatives on Hyperliquid, with the SPCX perpe...
After Nearly 800% Explosion, SK Hynix Debuts on Nasdaq
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...
Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Anthropic's Used Iran Strikes and Crypto Risks for Investors
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Willdan Stock Skyrocketing: Fund Cashout Shocks Investors
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status